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Moxibustion therapy has been used in East Asian medicine for more than a thousand years. However, there are some problems
associatedwiththistherapyinclinicalpractice.Theseproblemsincludelackofcontroloverthetreatmenttemperature,emissionof
smoke, and uneven temperature distribution over the treatment region. In order to resolve these problems, we developed a precise
temperature-controldeviceforuseasanalternateforconventionalmoxibustiontherapy.Inthispaper,wedescribethetreatmentof
a single patient with paralytic ileus that was treated with moxibustion. We also describe an evaluation of temperature distribution
on the skin surface after moxibustion therapy, the development of a heat-transfer control device (HTCD), an evaluation of the
HTCD, and the clinical eﬀects of treatment using the HTCD. The HTCD we developed can heat the skin of the treatment region
uniformly, and its eﬀect may be equivalent to conventional moxibustion, without the emission of smoke and smell. This device
can be used to treat ileus, abdominal pain, and coldness of abdomen in place of conventional moxibustion in modern hospitals.
1.Introduction
In East Asian medicine, a local thermal therapy known as
moxibustion is widely used to treat several conditions,
including gastrointestinal disorders, neurodegenerative dis-
eases, cerebrovascular diseases, and cardiovascular diseases
[1–3]. In moxibustion therapy, skin is heated by burning
moxa. Because the direct burning of moxa on the skin can
be dangerous, materials like salt, ginger, or garlic may be
used as a buﬀer between the skin and the moxa [4–7]. There
havebeenseveralstudiesreportingtheeﬀectsofmoxibustion
therapy [4–7] .H o w e v e r ,t h e r ea r es o m ep r o b l e m sa s s o c i a t e d
with the application of this treatment in clinical practice.
Moxibustion treatment temperature is dependent upon the
expertise of the treating doctor or practitioner. Thermal
damage to tissue begins at temperatures above 44◦C[ 8].
Therefore, patients who have lost temperature sensitivity are
at risk for burns during moxibustion therapy. A uniform
temperature distribution is important when conducting
thermal therapy in order to avoid burning the patient and
to heat the treatment region to the desired therapeutic
temperature. Additionally, the temperature distribution in
the treatment region is nonuniform. Another problem
associated with moxibustion therapy is the emission of2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Abdominal X-ray radiographs of a 95-year-old paralytic ileus patient. (a) Radiograph taken at the time of hospital admission, (b)
radiograph taken 18 days after moxibustion therapy.
smoke. In order to resolve these problems, we developed a
precise temperature-control device for use as an alternate for
conventional moxibustion therapy.
In this paper, we describe a case of repetitive ileus that
was treated by moxibustion. We also describe an evaluation
of temperature distribution on the skin surface after con-
ventional moxibustion therapy, the development of a heat-
transfer control device (HTCD) for use as an alternate for
conventional moxibustion therapy, an evaluation of the
HTCD, and the clinical eﬀects of the HTCD.
2. ClinicalUsage of Moxibustionto
Treat Ileus: A Case Report
A 95-year-old man was referred to Tohoku University
Hospital from a local clinic for the treatment of nausea and
abdominal pain. The patient was admitted to the hospi-
tal and diagnosed with paralytic ileus. He underwent an
operation for inguinal herniation 15 years before seeking
treatment at our hospital and had experienced ileus twice
in the preceding year. The patient indicated he had been
experiencing symptoms of constipation and abdominal pain
for 5 days. After hospitalization, he was prescribed aperients.
AnabdominalX-rayradiographindicatedgasintheintestine
and air-ﬂuid level (Figure 1(a)). There was no indication of
tumor or strangulation in either the small or large intestine,
and the diagnosis of paralytic ileus was conﬁrmed. Because
the patient experienced repeated ileus during treatment with
medication, we added moxibustion therapy to his treatment
regimen (Figure 2). Following moxibustion therapy around
umbilical region for 10 days, the constipation was relieved.
The patient no longer experienced nausea and abdominal
pain and he was able to resume eating meals. An abdominal
radiograph also indicated improved ileus (Figure 1(b)).
Moxibustion therapy was repeated daily, and the patient was
able to defecate without anticonstipation drugs. After his
Figure 2: A type of conventional moxibustion therapy. Salt was
used as a buﬀer between the skin and the moxa.
discharge, the patient continued to receive regular weekly
moxibustion therapy in the outpatient clinic.
3. Temperature Distributionon
the Skin by Conventional Moxibustion
(Modiﬁed from [9])
The temperature distribution on the skin by moxibustion
should be assessed to avoid the skin burning. Therefore, we
investigated temperature distribution on the skin after con-
ventionalmoxibustiontherapyinhuman.Figure 3showsthe
variation over time in the temperature distribution on the
skin surface measured using thermography (Advanced Ther-
moTVS-500;NipponAvionicsCo.,Ltd.,Tokyo,Japan)just
after conventional moxibustion therapy (Figure 2). In this
experiment, the abdominal area of 34-year-old healthy male
volunteer was heated by moxibustion with a salt buﬀer
between the skin and moxa. As shown in Figure 3, the
temperature on the central part of the abdominal area
reached 44◦C, indicating the risk of burns from heating theEvidence-Based Complementary and Alternative Medicine 3
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Figure 3: Spatial distribution of abdominal skin temperature from
the central point at 0, 30, 110, and 350s after completion of
moxibustion therapy. The way of moxibustion is shown in Figure 2
(modiﬁed from [9]).
skin for long periods of time, because the denaturation of
protein occurs at temperatures greater than 44◦C[ 8]. In
moxibustion therapy, the treatment temperature is adjusted
basedontheexpertiseofdoctorsandfeedbackfrompatients.
Therefore, patients who have lost heat sensitivity like aged
person are at increased risk of burns during moxibustion
therapy. It is safer to control temperature precisely when the
treatment is applied to human.
4.DevelopmentofanHTCD(Modiﬁedfrom[9])
According to the data of temperature distribution on the
skin and the style of conventional moxibustion, we have
developed a precise temperature control devise. A schematic
diagram of the HTCD is provided in Figure 4. This device
consists of heating disk and a control apparatus. The copper
heating disk is 100mm in diameter. Copper was used to
form the heating disk because the high thermal conductivity
of this material permitted uniform heating of the disk. A
thermistor was implanted into the heating disk in order to
monitor its temperature within 0.1◦C. This device reduces
the risk of burns because the temperature of the heating disk
can be controlled to avoid exceeding the target temperature.
This device is convenient for medical doctors because it does
not emit smoke, control of device temperature is easy, and
there is no risk of burns to patients. Therefore, this devise as
a modern “moxibustion” therapy can be used in hospitals.
Furthermore, we have demonstrated the therapeutic eﬀects
of this device on many patients.
5. Temperature Distribution on
the Skinby HTCD
5.1. Methods (Modiﬁed from [9]). To conﬁrm the perfor-
mance of the abdominal heating controller, we evaluated
the controllability of the temperature, heating rate, and
uniformity of the temperature distribution on the skin
surface. A 24-year-old healthy male volunteer lay down on
his back on a bed in the experiment room. The temperature
of the experiment room was maintained at 25◦C. The
HTCD was placed directly on the skin of the subject’s
abdominal area (Figure 5). The temperature of heating disk
was set to 42◦C and the abdominal area was heated for
about 12 minutes. Skin surface temperature was recorded by
temperature sensor in the disk. The experiment was repeated
4 times with the interval of 2 hours and in each experiment,
the incremental rate of temperature increase was altered.
After heating for 12 minutes, the heating disk was removed
fromthesubject’sabdomenandthetemperaturedistribution
of the skin surface was measured using thermography.
5.2. Results. Figure 6 shows the result in the variation of the
incremental rate of temperature on the skin surface of
the subject’s abdominal area. In all 4 repetitions of the
experiment, the temperature of the heating disk increased
to the target temperature, but did not exceed it. This
conﬁrms that there is no risk of skin burns to patients
from high temperatures. Moreover, it was conﬁrmed that
the temperature of the disk is controllable. The temperature
distribution on the skin at diﬀerent time points after the
removal of a heating disk set to 42◦C is shown in Figure 7.
Skin temperature decreased almost uniformly. This conﬁrms
thatthetemperaturedistributionoftheheatingdiskandthat
of the subject’s abdominal area were almost uniform during
the procedure. Therefore, the HTCD is able to uniformly
heat the abdominal area of patients to a precise target
temperature.
6. ClinicalApplication[10,11]
6.1. Methods. To conﬁrm the eﬀects and safety of HTCD,
the thermal therapy was conducted on 26 healthy volunteers
(male; 24 and female; 2) with a mean age of 30.8 ± 6.8y e a r s
(range, 21–44 years). The HTCD was placed on the skin
of the paraumbilical region for 20 minutes. We measured
blood ﬂow through the superior mesenteric artery (SMA)
continuously from rest to 40 minutes after removal of the
HTCD. (Figure 5). There are several acupoints located at
the paraumbilical region. In particular, the acupoint of CV8
and ST25 is considered to inﬂuence the stomach, spleen,
and intestines in traditional East Asian medicine [12]. This
size of the heating disk can cover these important acupoints
for the treatment of digestive diseases. The SMA supplies
blood to the whole small intestine, except the superior part
of the duodenum, as well as the cecum, the ascending colon,
and most of the transverse colon. Therefore, we used SMA
blood ﬂow to investigate the changes in intestinal blood ﬂow
resultingfromthermalstimulation.Wemeasuredcirculation
in the SMA using an ultrasound system (Prosound α10;
A l o k aC o . ,L t d ,T o k y o ,J a p a n ) .P u l s e dD o p p l e rs i g n a l sw e r e
used to acquire SMA measurements within 2 to 3cm
of the origin of the artery [13, 14]. To ensure accurate
measurement, we employed a Doppler angle of 60◦ or less4 Evidence-Based Complementary and Alternative Medicine
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Figure 4: (a) Schematic diagram of an abdominal heating controller, (b) picture of heat-transfer control device.
[15, 16]. Blood ﬂow volume was recorded 3 times during 3
diﬀerent cardiac cycles and averaged for each subject in an
eﬀort to minimize errors [13].
Subjects rested in the supine position in a quiet, air-
conditioned room (temperature, 25-26◦C) during the entire
experiment. After positioning the ultrasound system, sub-
jects rested for 10 minutes. The HTCD was set to 40◦Ca n d
placed on the skin of the paraumbilical region (Figure 5).
The HTCD was left in place for 20 minutes. After 5 minutes,
if tolerated by subjects, the temperature was increased to
41◦C. The target temperature of the disk was set at 40-41◦C
for safety to avoid a skin burn. The device was removed after
20min of thermal stimulation.
Statistical analysis was performed with SPSS software
(version 16.0, SPSS Japan Inc., Tokyo, Japan). Repeated
measures analysis of variance with a Tukey post hoc test was
used for statistical comparison with baseline. The % change
of blood ﬂow volume in the SMA at each time was calculated
in relation to the baseline value. Results are presented as the
means and SD. P<0.05 was used to indicate signiﬁcance in
all statistical tests.
6.2. Results. Figure 8 shows the result in the % change of
blood ﬂow volume in the SMA. The blood ﬂow volume in
the SMA was signiﬁcantly higher during thermal stimulation
(P<0.01), 10 and 20 minutes after the end of thermal
stimulation (P<0.01), and 30 minutes after the end of
thermal stimulation (P<0.05), as compared to the volume
before placement of the HTCD (Figure 8). There were no
complications such as local burns, pain, discomfort or other
problems that required treatment.
7. Discussion
In this report, we described a case of ileus that was suc-
cessfully treated with moxibustion, reported the distribution
of skin temperature following conventional moxibustion,
described the development of a precise temperature-control
Figure 5: Abdominal thermal therapy on the abdomen by using a
heat-transfer control device.
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Figure 6: Skin surface temperature of a single subject during 12
minutes of stimulation by a heat-transfer control device set to
42◦C. The device was set to increase from body temperature to the
target temperature at the following rates: 0.6◦C/min, 1.1◦C/min,
1.5◦C/min, and 5.6◦C/min (modiﬁed from [9]).Evidence-Based Complementary and Alternative Medicine 5
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Figure 7: Spatial distribution of abdominal skin temperature
after stimulation with a heat-transfer control device. The target
temperature was set at 42◦C. Measurements were taken 0, 30, 110,
and 350 seconds after device removal. (Modiﬁed from [9]).
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Figure 8: The % change of blood ﬂow volume in the superior
mesenteric artery during and after thermal stimulation of the
abdomen. Data are presented as means and SD. ∗P<0.05, ∗∗P<
0.01 versus baseline. TS, thermal stimulation.
device, and reported the results of an experiment demon-
strating the eﬃcacy of the devise.
Traditional East Asian medicine has a long history and
the administration of herbal medicine, acupuncture, and
moxibustion therapies depends on the experience of the
treating doctors or practitioners. The problems associated
with moxibustion therapy, such as diﬃculty of temperature
control, smoke, and smell make it diﬃcult to use in
modern hospitals. These problems pose real risks to patients.
In general clinical practice, there is a possibility of skin
burning of a patient with low temperature sensitivity during
moxibustion. Another patient suﬀered an attack of bronchial
asthma during moxibustion therapy that was induced by the
smoke.
The eﬀects of moxibustion result from the heat, smell,
and smoke generated by the procedure. The temperature-
control device that we described in this study simulates the
heat of moxibustion, but does not produce either the smoke
or smell associated with this treatment. As this device can be
used to control skin surface temperature to within 0.1◦C, it
canbeusedinmodernhospitalsasasaferandmoregenerally
useful device than conventional moxibustion.
Mesenteric ischemia results from decreased blood ﬂow
to the bowels and causes several symptoms such as pain,
nausea, and vomiting. Nonocclusive mesenteric ischemia is
an acute mesenteric circulatory disorder, which is induced
by vasospasm [17]. Chronic mesenteric ischemia is usu-
ally caused by atherosclerosis [18]. In these conditions,
the pathophysiology is same as the mesenteric ischemia.
The treatment of mesenteric ischemia involves reperfusion
through drug therapy or vessel reconstruction. Sometimes
vasodilative drugs are selected as a conservative treatment
modality[17–19].Inthecurrentstudy,wedemonstratedthat
SMAbloodﬂowvolumeincreaseswithlocalthermaltherapy.
The treatment of local thermal therapy with HTCD might
be useful for increasing blood ﬂow volume in the cases of
mesenteric ischemia. During thermal stimulation, intestinal
peristalsis accelerated along with the increase in blood ﬂow
volume (data not shown). Thus, thermal stimulation not
only increases the blood ﬂow volume, but also improves
intestinal motility. Abdominal thermal therapy might be
useful for patients with low SMA blood ﬂow, paralytic ileus,
or chronic constipation. Future study of the eﬀect of thermal
stimulation on patients with such disorders is warranted.
HTCDs have been used to treat the abdominal disorders,
pain, and coldness in about a total of 600 patients at Tohoku
UniversityHospital.Overthepast3years,therehavebeenno
reportedsideeﬀectsassociatedwiththeuseofthisdevice.We
conduct clinical trials to investigate its clinical eﬀects in the
patients of old cerebral infarction with chronic constipation.
8. Conclusion
The HTCD described in this paper was developed based
on conventional moxibustion therapy. The temperature of
this device can be controlled precisely, and it is safer
than conventional moxibustion. Our studies suggest the
usefulness of this device for the treatment of adnominal
disorders, constipation, pain syndromes, and coldness in
place of moxibustion in hospital settings.
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